The Relationship Between Kidney Function and Angiographically-Derived SYNTAX Score

Canadian Journal of Cardiology

Volumn 27, Issue 6, 2011, Pages 768-772

  Yan, Li qiu ^a,b,c   Guo, Li jun ^a,b   Zhang, Fu chun ^a,b   Gao, Wei ^a,b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION COEFFICIENT; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERLIPIDEMIA; KIDNEY DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PERCUTANEOUS CORONARY INTERVENTION; RENOVASCULAR HYPERTENSION; SMOKING HABIT; SYNTAX SCORE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; CAUSE OF DEATH; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 82155185201     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2011.04.004     Document Type: Article

References (40)

1. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
2. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
3. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32(suppl 3):S112-S119.
4. Joki N., Hase H., Nakamura R., et al. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997, 12:718-723.
5. Levin A., Singer J., Thompson C.R., et al. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996, 27:347-354.
6. Beattie J.N., Soman S.S., Sandberg K.R., et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001, 37:1191-1200.
7. Shlipak M.G., Heidenreich P.A., Noguchi H., et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002, 137:555-562.
8. Walsh C.R., O'Donnell C.J., Camargo C.A., et al. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 2002, 144:1003-1011.
9. Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002, 137:563-570.
10. McCullough P.A., Soman S.S., Shah S.S., et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000, 36:679-684.
11. Wison S., Foo K., Cunningham J., et al. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 2003, 91:1051-1054.
12. Best P.J., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002, 39:1113-1119.
13. Reis S.E., Olson M.B., Fried L., et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002, 105:2826-2829.
14. Szczech L.A., Best P.J., Crowley E., et al. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. Circulation 2002, 105:2253-2258.
15. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005, 1:2197.
16. Serruys P., Onuma Y., Garg S., et al. Assessment of the SYNTAX score in the Syntax study. Eurointervention 2009, 5:50-56.
17. SYNTAX score calculator SYNTAX Working Group, Accessed November 2009. http://www.syntaxscore.com.
18. Valgimigli M., Serruys P.W., Tsuchida K., et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007, 99:1072-1081.
19. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
20. Serruys P., Onuma Y., Garg S., et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010, 55:1093-1101.
21. Capodanno D., Di Salvo M.E., Cincotta G., et al. Usefulness of the SYNTAX Score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009, 2:302-308.
22. Van Gaal W.J., Ponnuthurai F.A., Selvanayagam J., et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 2009, 135:60-65.
23. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
24. Xue J.L., Ma J.Z., Louis T.A., et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol 2001, 12:2753-2758.
25. Blackman D.J., Pinto R., Ross J.R., et al. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 2006, 151:146-152.
26. Hillis G.S., Croal B.L., Buchan K.G., et al. Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up. Circulation 2006, 113:1056-1062.
27. Lemos P.A., Arampatzis C.A., Hoye A., et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol 2005, 95:167-172.
28. Na K.Y., Kim C.W., Song Y.R., et al. The association between kidney function, coronary artery disease, and clinical outcome in patients undergoing coronary angiography. J Korean Med Sci 2009, 24(suppl):S87-S94.
29. Reddan D.N., Szczech L.A., Tuttle R.H., et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 2003, 14:2373-2380.
30. Ong A.T., Serruys P.W., Mohr F.W., et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006, 151:1194-1204.
31. Wykrzykowska J., Garg S., Girasis C., et al. Value of the Syntax Score (SX) for risk assessment in the "Allcomers" Population of the Randomized Multicenter LEADERS Trial. J Am Coll Cardiol 2010, 56:272-277.
32. Ruperto C., Capodanno D., Blundo A., et al. Impact of diabetes mellitus on long-term follow-up of percutaneous coronary intervention based on clinical presentation of coronary artery disease. J Cardiovasc Med 2011, 12:405-410.
33. Lin T., Liu J.C., Chang L.Y., et al. Association of metabolic syndrome and diabetes with subclinical coronary stenosis and plaque subtypes in middle-aged individuals. Diabet Med 2011, 28:493-499.
34. Zhang Z.J., Marroquin O.C., Stone R.A., et al. Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarction. Am Heart J 2010, 160:979-986.e1.
35. Pan C.Y., Ho L.T., Soegondo S., et al. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. Diabetes Technol Ther 2008, 10:397-403.
36. Zhang M., Que B., Nie S.P., et al. The effect of pre-hospital statins therapy on incidence of in-hospital death and total MACCE in patients with PCI. J Clin Pharm Ther 2008, 33:613-617.
37. Zhang Z.J., Marroquin O.C., Weissfeld J.L., et al. Beneficial effects of statins after percutaneous coronary intervention. Eur J Cardiovasc Prev Rehabil 2009, 16:445-450.
38. Gibson C.M., Pride Y.B., Hochberg C.P., et al. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. J Am Coll Cardiol 2009, 54:2290-2295.
39. Xinwei J., Xianghua F., Jing Z., et al. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Am J Cardiol 2009, 104:519-524.
40. Luk A.O., Yang X., Ma R.C., et al. Association of statin use and development of renal dysfunction in type 2 diabetes--the Hong Kong Diabetes Registry. Diabetes Res Clin Pract 2010, 88:227-233.